The Medicines Company to Participate in the 2012 Barclays Capital Global Healthcare Conference

(firmenpresse) - PARSIPPANY, NJ -- (Marketwire) -- 03/07/12 -- The Medicines Company (NASDAQ: MDCO) will present at the 2012 Barclays Capital Global Healthcare Conference on Tuesday, March 13th, in Miami, FL beginning at 4:15pm Eastern Time. Glenn Sblendorio, President and Chief Financial Officer, will provide a company overview.

The sessions will be webcast with a link available at The Medicines Company's website .

The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .



Contact:
Michael Mitchell
The Medicines Company
973-290-6000

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 07.03.2012 - 21:15 Uhr
Sprache: Deutsch
News-ID 122889
Anzahl Zeichen: 0

contact information:
Town:

PARSIPPANY, NJ

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 227 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"The Medicines Company to Participate in the 2012 Barclays Capital Global Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

The Medicines Company (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

The Medicines Company to Participate in Upcoming Investor Conference Webcasts ...

PARSIPPANY, NJ -- (Marketwired) -- 11/27/13 -- The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference on December 4th at 12:30 PM Eastern Time. MDCO is also scheduled to present at the Opp ...

European Medicines Agency Accepts Marketing Authorization Application for The Me ...

PARSIPPANY, NJ -- (Marketwired) -- 11/21/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational hemostatic agent ...

FDA Grants QIDP Designation to The Medicines Company's Investigational Anti ...

PARSIPPANY, NJ -- (Marketwired) -- 11/12/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has designated oritavancin as a Qualified Infectious Disease Product (QIDP). The QIDP designation pr ...

Alle Meldungen von The Medicines Company